Accessibility Menu
 
Inspecs Group Plc logo

Inspecs Group Plc

(LSE) SPEC

Current Price$83.00
Market Cap$8.49B
Since IPO (2020)-57%
5 Year-77%
1 Year+99%
1 Month+1%

Inspecs Group Plc Financials at a Glance

Market Cap

$8.49B

Revenue (TTM)

$387.97M

Net Income (TTM)

$12.30M

EPS (TTM)

$-8.06

P/E Ratio

-10.36

Dividend

$0.00

Beta (Volatility)

-0.43 (Low)

Price

$83.00

Volume

8,300

Open

$83.00

Previous Close

$83.00

Daily Range

$83.00 - $83.00

52-Week Range

$38.00 - $87.00

SPEC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Inspecs Group Plc

Industry

Healthcare Equipment and Supplies

Employees

1,654

CEO

Richard David Peck

Headquarters

Bath, BA1 3AU, GB

SPEC Financials

Key Financial Metrics (TTM)

Gross Margin

45%

Operating Margin

1%

Net Income Margin

-4%

Return on Equity

-3%

Return on Capital

2%

Return on Assets

-4%

Earnings Yield

-9.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.49B

Shares Outstanding

101.67M

Volume

8.30K

Short Interest

0.00%

Avg. Volume

981.38K

Financials (TTM)

Gross Profit

$103.45M

Operating Income

$3.41M

EBITDA

$15.75M

Operating Cash Flow

$7.20M

Capital Expenditure

$2.92M

Free Cash Flow

$4.28M

Cash & ST Invst.

$23.96M

Total Debt

$62.47M

Inspecs Group Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$97.62M

-12.2%

Gross Profit

$44.54M

-11.9%

Gross Margin

45.63%

N/A

Market Cap

$8.49B

N/A

Market Cap/Employee

$5.13M

N/A

Employees

1,654

N/A

Net Income

$4.61M

-321.4%

EBITDA

$9.99M

-17.6%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$35.97M

+12.0%

Accounts Receivable

$31.23M

-10.7%

Inventory

$40.58M

-4.2%

Long Term Debt

$43.90M

-14.8%

Short Term Debt

$14.74M

-3.2%

Return on Assets

-4.02%

N/A

Return on Invested Capital

2.08%

N/A

Free Cash Flow

$5.73M

-19.1%

Operating Cash Flow

$6.29M

-26.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
STX.LShield Therapeutics plc
$9.44+6.07%
VLG.LVenture Life Group plc
$65.50+1.39%
HEMO.LHemogenyx Pharmaceuticals Plc
$960.00-0.57%
EAH.LECO Animal Health Group plc
$88.00-2.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About SPEC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.